CA
NZ
UK
AU
IND
US
• Four Molecules Identified: PMGC Holdings (NASDAQ: ELAB), through NorthStrive, said four small molecules boosted ANT1 expression in human skeletal muscle cells.
Although momentum has weakened considerably, all three names continue to trade near important technical inflection points where buyers are likely to re-emerge if the broader AI and digital infrastructure theme remains intact.
ONTO Inc. (NYSE: ONTO) — Bullish Trend Remains Intact Despite Sharp Profit-Taking Following a Strong Breakout to New Highs
Oscar Health (NYSE: OSCR) — Strong Breakout Signals Continued Bullish Momentum as Buyers Push Toward New Highs
• Initial equity award to Dr. Kreher valued at approximately $450,000, with annual grants of about $300,000.
• The presentation is available on the company’s investor relations platform.
• Provectus Biopharmaceuticals (OTC: PVCT) approved the conversion of $542,500 in accrued director fees into Series D-1 Preferred Stock.
• Stoke Therapeutics (NASDAQ: STOK) has fully enrolled participants in its Phase 3 EMPEROR study for zorevunersen, a potential Dravet syndrome therapy.
• Tenax Therapeutics and Orion Corporation finalized a supply agreement for levosimendan, with provisions for renewals.
• The board appoints Han Eui Seok as Chair of the Compensation Committee, effective June 30, 2026.
Please wait processing your request...